title: Direct effects of PPARα agonists on retinal inflammation and angiogenesis may explain how fenofibrate lowers risk of severe proliferative diabetic retinopathy.
authors.affiliation: Department of Ophthalmology and Visual Sciences, University of Michigan College of Medicine, Kellogg Eye Center, Ann Arbor, Michigan, USA. sabcouwe@umich.edu
authors.forename: Steven F
authors.initials: SF
authors.lastname: Abcouwer
mesh_terms: D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003930:Diabetic Retinopathy / Q000188:drug therapy*; D011345:Fenofibrate / Q000627:therapeutic use*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D047493:PPAR alpha / Q000819:agonists*
chemical_list: D007004:Hypoglycemic Agents; D047493:PPAR alpha; D011345:Fenofibrate